* A corporate client of Hybridan LLP.
** Potential means Intention to Float (ITF) or similar announcement has been made.
***Arranged by type of listing and date of announcement.
****Alphabetically arranged and priced on Share Price and Market Capitalisation during the time of writing on the day of Publication.
Admissions:
Coastal Africa Group (CAG.L) Theinvesting company focused on acquiring and investing in the oil and gas sector, energy infrastructure, energy services and energy assets across West Africa, announced its first day of dealings on the AIM market. The Company raised gross proceeds of approximately £17.36m at a price of 161 pence per share. On Admission, Coastal will have 135,783,627 Ordinary Shares in issue with a market capitalisation of approximately £218.66m.
Delistings:
Essensys (ESYS.L) left AIM.
What’s baking in the oven?
Potential IPOs:***
3 June: Reveille Resources has announced its intention to IPO onto AQSE. The strategy is focused on identifying and advancing uranium exploration opportunities in assets that have benefited from significant historical expenditure and technical work, but which may not have achieved full value realisation due to geopolitical, technological, financial, or historical factors. Reveille’s initial focus is on two historical uranium deposits in Lombardy, northern Italy. Deal details TBC and expected Admission date is 17 June.
17 March: Vista Parcs Group has announced its intention to IPO onto AIM. The newly incorporated entity is proposing to acquire a portfolio of 13 UK-based holiday and residential parks currently owned by Barney Group 2 Ltd (BG2) and operated by Baslow Parks Ltd. Deal details TBC and expected Admission date anticipated late June 2026.
Reverse Transactions:***
19th December 2025: Talon Resources (TAR.L), previously Medcaw Investments, the Company focused on identifying and acquiring prospective mining projects in the precious metals sector, with a primary focus on gold and other high-value commodities announced that it has entered into binding heads of terms (which includes an exclusivity agreement until 31 October 2026) with Ulvestone Ltd in respect of the proposed acquisition by the Company of 90% of the legal and beneficial interest in certain mineral exploration licences located in Ontario, Canada. The aggregate consideration payable by Medcaw is £4.17m, to be satisfied £70k in cash on execution of the definitive share purchase agreement, £100k in cash on AIM Admission, and £4m satisfied through the issue of new ordinary shares in Medcaw at a price of 1.5p per share, to be issued on AIM Admission. The indicative timetable in relation to the Cancellation and proposed re-admission to trading on AIM has been revised and is now expected to take effect on 23 June.
Market Movers:***
1st June: Mendell Helium (AQSE: MDH), the helium production company with operations in Kansas, announced its intention to move to AIM during the week beginning 15 June. No new Ordinary Shares are being issued or allotted in conjunction with Admission to trading on AIM with an anticipated market capitalisation on Admission of approximately £15m.
Banquet Buffet****
London Stock Exchange: Main Market and AIM
Blackbird 1.8p £8.60m (BIRD.L)
The technology licensor, developer and seller of the cloud native video editing platform, Blackbird, and developer of the online collaborative video editing and content creation platform, elevate.io, updates on trading ahead of the AGM today. In 2025 the Blackbird division delivered a net profit of c.£0.38m and positive cash flow. The platform continues to be used on some of the world's most high-profile content, including at the global winter games held in Italy. elevate.io has been enhanced dramatically over the last 12 months as features and functionality are added to the platform. The marketing focus will be on the ideal customer profile and monthly research cycles will provide regular feedback on elevate.io's progress within the marketing community.
Cornish Metals 108.5p £136.10m (TIN.L)
The mineral exploration and development company focused on advancing its wholly owned and permitted South Crofty tin project in Cornwall, updates on activities at South Crofty. The surface civil works at Roskear shaft are complete, with the winder house under construction and the Front-End Engineering Design (FEED) of the process plant completed with Detailed Engineering being progressed. The excavation at the pre-concentration building is approximately 50% complete, with civil works expected to continue as planned throughout 2026. The current tin price of about $53,000/tonne further supports the South Crofty project economics with the NPV6% at current spot market prices estimated at approximately £500m.
Dekel Agri-Vision 0.375p £4.50m (DKL.L)
The West African agriculture company focused on building a portfolio of sustainable and diversified projects updates on operations. The Crude Palm Oil (CPO) Production in May materially increased by 31.9% against the prior period representing the third consecutive month of year-on-year production growth. The CPO extraction rate improved to 22.3%, an increase of 3.7% compared to May 2025. The Raw Cashew Nut (RCN) operation volumes and prices remained stable. The quarterly production and sales data for the Cashew Operation will be reported in July 2026. The performance positions the Company to deliver a strong first half of 2026. International Palm Oil prices are continuing to trade at elevated levels and market conditions remain supportive.
Diales Group 30p £15.80m (DIAL.L)
The global professional services consultancy to the construction and engineering industries reports Interims to March 2026. Revenue from continuing operations increased 10% to £23.7m (H1FY25: £21.6m) and gross profit increased by 19% to £6.8m (H1FY25: £5.7m). The PBT increased to £1.0m compared to £0.6m despite a slight fall in utilisation rate to 70.2% from 71.4%. Europe & Americas reported strong growth and Asia Pacific returned to profit against losses last time. Net cash increased year on year by £1.5m to £3.9m and the dividend is being maintained at 0.75p per share. Strong momentum with robust pipeline is reported heading into H2 and the Board are confident FY results will be at least in line with market expectations.
ECR Minerals 0.22p £7.8m (ECR.L)
The gold exploration and development company focused on Australia, updates on operational activities at its Raglan Gold Project in Queensland. The Company has completed several initiatives in recent weeks which gives it confidence that more consistent gold production and recovery outcomes can be achieved from the project. The Drone Lidar (Light Detection and Ranging) survey was completed across the Raglan Project area during May 2026 and the processing and interpretation of the survey data is currently underway. The interpreted data is expected to assist future mine planning, identify additional mining opportunities and support production scheduling activities. Mining operations to date have already identified areas with potentially higher gold grades, specifically gullies into the mainstream which can act as traps for alluvial gold.
Fulcrum Metals 9.25p £14.20m (FMET.L)
The company pioneering the use of innovative cyanide-free technologies announced that its wholly owned subsidiary, Fulcrum EnviroTech Corp. has signed a contract with Test Design Implement Solutions for the deployment and operation of a standalone pilot plant in Ontario, Canada. The Pilot Plant will utilise the cyanide-free leach technology to process material from Fulcrum's Teck-Hughes project. Fulcrum holds exclusive rights to deploy Extrakt's proven cyanide-free technology across legacy gold mine waste sites within the Timmins and Kirkland Lake mining districts of Ontario which have collectively produced more than 110m ounces of gold over the past century and are estimated to contain more than 70 documented legacy mine waste sites, providing a significant pipeline of potential future reclamation and metal recovery opportunities. The establishment of this platform is a significant milestone as it supports future mine waste recovery opportunities.
H-Power 13.34p £145.50m (HPOW.L)
The provider of ammonia-based low carbon hydrogen production and hydrogen-to-power solutions at a commercially viable price point reports on the six months to April 2026. Revenue increased to £253k from £17k (Six-months to April 2025) with a reduced LPT of £5.8m from £10.1m. The total cash available is £17.4m compared to £4.3m. The business has progressed considerably as it has begun to build positive commercial momentum. A 5,000kg hydrogen sale agreement was signed with Protium, the UK's first bulk green hydrogen reseller for cracked ammonia. There is an agreement with Speedy Hire, to open an H-Power depot within Speedy Hire’s flagship London Gateway depot, to serve anticipated demand for infrastructure projects. The strong balance sheet and a growing order book allows the Board to be confident of delivering scalable commercial success.
Light Science Technologies Holding 2.1p £19.70m (LST.L)
The innovative technology and manufacturing business, providing real-world solutions targeting issues including global food security and fire safety, reports a manufacturing partnership. It’s between its Contract Electronics Manufacturing division and a provider of workforce management and access control solutions serving the construction and infrastructure sectors. An initial manufacturing order of approximately £70,000 has already been received. In addition, the Partner has indicated the potential for total orders of up to £200,000, also for the current financial year. The project comprises the manufacture of four printed circuit board assemblies for industrial control systems relating to fire safety. The partner is a global group that is one of the world's largest providers of intelligent access and security solutions, with operations in more than 70 countries worldwide and annual revenues exceeding £12bn.
Power Probe 69p £50.90m (PWR.L)
The producer of automotive electrical diagnostic tools for professional service technicians updates on trading at its AGM. The Group's focus is on Power Probe branded products and its higher margin private brands business where pricing initiatives have been absorbed by the market so improving the gross margins. The planned timing of new product launches remains unchanged, and 2026 revenues are expected to be second half weighted. The Middle East has had not affected import routes via the Pacific Ocean and Panama Canal. Trading in 2026 remains encouraging and in line with management's expectations.
Aquis Market:
BWA Group 0.475p £4.60m (AQSE:BWA)
The mining investment company with permits in Cameroon and Canada releases survey results. These are for the ground magnetic survey from the Aracari Gold Project and an update on the progress of concurrent mapping and sampling programmes. The focus of this fieldwork has been the Bandjoukri Ouest exploration permit to the west of the Benue River and strike extensions from Oriole Resources PLC's Mbe exploration permit. This hosts an announced Inferred Mineral Resource Estimate of 1.23 m ounces (Moz) of gold, with a weighted average grade of 1.08 grammes per tonne (g/t). Artisanal gold mining sites have so far been identified in the granite and mylonite zones, and soil sampling programme of more than 500 samples has been completed over gold-bearing structures and ensure a more robust targeting process which integrates geology, geochemistry, and geophysics and not all the samples have not yet geochemically assayed. The CEO is highly encouraged by the initial results and is planning further exploration programmes to the east in Bandjoukri Ouest to unlock the broader potential of the permit
Status of this Note and Disclaimer
This document has been provided as a general market commentary and is issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as investment advice; a recommendation; an offer to sell; nor solicitation of any offer to buy any security or other financial instrument. Nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. The information has been provided without taking into account the investment objective, financial situation or needs of any particular person. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
As market commentary, this document is not investment research or a research recommendation for regulatory purposes as it does not constitute substantive research or analysis. It is not subject to any prohibition on dealing ahead of the dissemination of investment research although Hybridan LLP maintains related internal systems and controls in connection with such dealing.
This document should not be relied upon as being an independent or impartial view of the subject matter. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result, both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
This document is not intended to be an invitation or inducement to engage in investment activity. In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are categorised by Hybridan LLP as either a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority's Conduct of Business Sourcebook) (all such persons referred to in (i) and (ii) together being referred to as "relevant persons"). This document must not be acted on or relied up on by persons who are not relevant persons. For the avoidance of doubt, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority's Conduct of Business Sourcebook.
The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. The information may contain projections or other forward-looking statements regarding future events, targets or expectations. There is no assurance that such events or expectations will be achieved, and actual results may be significantly different from that shown here. The information is based on current market conditions, which will fluctuate and may be superseded by subsequent market events or for other reasons. Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein.
References to specific securities, asset classes and financial markets are for illustrative purposes only. Past performance is no guarantee of future results. Information and opinions presented have been obtained or derived from sources which Hybridan LLP reasonably believed to be reliable however no representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.
To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any losses arising in any way from use of all or any part of the information in this document including, for the avoidance of doubt, direct or indirect or consequential loss or damage (including lost profits).
Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom or any other jurisdiction in any part of the world.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication.
In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
Unless otherwise stated, Hybridan LLP owns the intellectual property rights and any other rights in this document. This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.
